These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 7846742

  • 1. Comparison of the effects of cyclosporin G (OG37-325), cyclosporin A, and their metabolites on the release of endothelin and prostacyclin from primary renal and aortic endothelial cell lines.
    Langman LJ, Yatscoff RW.
    Ther Drug Monit; 1994 Oct; 16(5):450-7. PubMed ID: 7846742
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the effects of cyclosporine and its metabolites on the release of prostacyclin and endothelin from mesangial cells.
    Copeland KR, Yatscoff RW.
    Transplantation; 1992 Mar; 53(3):640-5. PubMed ID: 1549858
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Drug resistance in multiple myeloma: cyclosporin A analogues and their metabolites as potential chemosensitizers.
    Pilarski LM, Yatscoff RW, Murphy GF, Belch AR.
    Leukemia; 1998 Apr; 12(4):505-9. PubMed ID: 9557608
    [Abstract] [Full Text] [Related]

  • 5. A comparison of the immunosuppressive effects of cyclosporine A and cyclosporine G in vivo and in vitro.
    Rayat G, Yatscoff R, Silverman R, McKenna R.
    Transplantation; 1993 Mar; 55(3):623-6. PubMed ID: 8456482
    [Abstract] [Full Text] [Related]

  • 6. Effects of cyclosporin A and dexamethasone on haemostatic and vasoactive functions of vascular endothelial cells.
    Huang LQ, Whitworth JA, Chesterman CN.
    Blood Coagul Fibrinolysis; 1995 Jul; 6(5):438-45. PubMed ID: 8589211
    [Abstract] [Full Text] [Related]

  • 7. Steady-state concentration of cyclosporin G (OG37-325) and its metabolites in renal transplant recipients.
    Langman LJ, Leichtman AB, Weitzel WF, Yatscoff RW.
    Clin Chem; 1994 Apr; 40(4):613-6. PubMed ID: 8149619
    [Abstract] [Full Text] [Related]

  • 8. Comparative pharmacokinetics and renal effects of cyclosporin A and cyclosporin G in renal allograft recipients.
    Gruber SA, Gallichio M, Rosano TG, Kaplan SS, Hughes SE, Urbauer DL, Singh TP, Lempert N, Conti DJ, Stein DS, Drusano G.
    J Clin Pharmacol; 1997 Jul; 37(7):575-86. PubMed ID: 9243350
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the effect of rapamycin and FK506 on release of prostacyclin and endothelin in vitro.
    Yatscoff RW, Fryer J, Thliveris JA.
    Clin Biochem; 1993 Oct; 26(5):409-14. PubMed ID: 7507804
    [Abstract] [Full Text] [Related]

  • 10. Effect of cyclosporin A and its metabolites and analogs on lipid peroxidation in rabbit renal microsomes.
    Sadeg N, Pham Huy C, Martin C, Warnet JM, Claude JR.
    Drug Chem Toxicol; 1993 Oct; 16(2):165-74. PubMed ID: 8486097
    [Abstract] [Full Text] [Related]

  • 11. Cyclosporine suppression of endothelial prostacyclin generation. A possible mechanism for nephrotoxicity.
    Voss BL, Hamilton KK, Samara EN, McKee PA.
    Transplantation; 1988 Apr; 45(4):793-6. PubMed ID: 3128899
    [Abstract] [Full Text] [Related]

  • 12. Experimental nephrotoxicity, hepatotoxicity and pharmacokinetics of cyclosporin G versus cyclosporin A.
    Burdmann EA, Andoh TF, Rosen S, Lindsley J, Munar MY, Elzinga LW, Bennett WM.
    Kidney Int; 1994 Mar; 45(3):684-91. PubMed ID: 8196271
    [Abstract] [Full Text] [Related]

  • 13. Comparative study of cyclosporin A, cyclosporin G, and the novel cyclosporin derivative IMM 125 in isolated glomeruli and cultured rat mesangial cells: a morphometric analysis.
    Potier M, Wolf A, Cambar J.
    Nephrol Dial Transplant; 1998 Jun; 13(6):1406-11. PubMed ID: 9641169
    [Abstract] [Full Text] [Related]

  • 14. Cross-reactivities of cyclosporin G (NVa2 cyclosporin) and metabolites in cyclosporin A immunoassays.
    Yatscoff RW, Langman LJ, LeGatt DF.
    Clin Chem; 1993 Jun; 39(6):1089-92. PubMed ID: 8504544
    [Abstract] [Full Text] [Related]

  • 15. Measurement of AM19 and other cyclosporine metabolites in the blood of liver transplant patients with stable liver function.
    Liu WT, Levy GA, Wong PY.
    Ther Drug Monit; 1995 Oct; 17(5):479-86. PubMed ID: 8585111
    [Abstract] [Full Text] [Related]

  • 16. Semipreparative chromatographic separation of cyclosporin G metabolites generated by microsomes from rabbits treated with rifampicin.
    Liu WT, Tamolang MB, Pang H, Ren Y, Wong PY.
    J Pharmacol Toxicol Methods; 1996 Jun; 35(3):121-9. PubMed ID: 8782089
    [Abstract] [Full Text] [Related]

  • 17. Metabolism of cyclosporin G in the mouse, rat, and dog.
    Mangold JB, Rodriguez LC, Wang YK.
    Drug Metab Dispos; 1995 Jun; 23(6):615-21. PubMed ID: 7587942
    [Abstract] [Full Text] [Related]

  • 18. Cyclosporine inhibits endothelial cell prostacyclin production.
    Rosenthal RA, Chukwuogo NA, Ocasio VH, Kahng KU.
    J Surg Res; 1989 Jun; 46(6):593-6. PubMed ID: 2499734
    [Abstract] [Full Text] [Related]

  • 19. Cyclosporine A-induced prostacyclin release is maintained by extracellular calcium in rat aortic endothelial cells: role of protein kinase C.
    Oriji GK.
    Prostaglandins Leukot Essent Fatty Acids; 1999 Aug; 61(2):119-23. PubMed ID: 10509867
    [Abstract] [Full Text] [Related]

  • 20. Implication of CYP 3A in the toxicity of cyclosporin G (CsG), cyclosporin A (CsA) and FK506 on rat hepatocytes in primary culture.
    Ellouk-Achard S, Martin C, Pham-Huy C, Duc HT, Thevenin M, Dutertre-Catella H, Warnet JM, Claude JR.
    Arch Toxicol; 1997 Aug; 71(7):437-42. PubMed ID: 9209689
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.